Congenital complete atrioventricular (AV) block is a rare neonatal disease. It is a passively acquired immune-mediated injury of the conduction system, triggered by transplacental passage of maternal anti-SSA/Ro and anti-SSB/La antibodies. Management of premature infants with symptomatic complete AV block is challenging. If medical treatment with a β-adrenergic agonist and inotropic drugs is not effective, early cardiac pacing should be considered. Here we report a case of congenital complete AV block in a low birth weight, preterm neonate, who was successfully treated with temporary transcutaneous pacing immediately after birth. Temporary transcutaneous pacing may be an option for the emergent management of a low birth weight preterm neonate with congenital complete AV block prior to permanent pacemaker implantation.
INTRODUCTION
Congenital atrioventricular (AV) block is a rare neonatal disease with an overall prevalence of one in 15,000-20,000 live births 1) . About 80-95% of neonates with isolated congenital AV block without structural heart disease are associated with neonatal lupus erythematosus. Congenital AV block is a passively acquired autoimmune disease, in which an inflammatory response is triggered by the transplacental passage of maternal anti-SSA/Ro and anti-SSB/La antibodies 2) . This immune-mediated inflammation results in myocardial tissue injury, fibrosis, and scarring of the conduction system 1, 2) . The conduction disturbance in the fetus, including first, second, and third-degree AV block, is progressive.
However, complete AV block is usually irreversible, and most patients need pacemaker implantation 3) .
Here we present the case of a low birth weight, preterm neonate with congenital complete AV block that was successfully managed with temporary transcutaneous pacing Figure 1A ), and he was therefore intubated, treated with surfactant, and provided with ventilator assistance.
His heart rate ranged between 50 and 60 bpm, O2 saturation was 93% by pulse oximetry, and blood pressure (BP) was undetected by automatic manometer. Continuous intravenous infusion of . These progressive conduction abnormalities can be prevented if detected and treated early, and it is recommend ed that antibody-positive mothers undergo close fetal echocardiographic surveillance in the early second trimester 4) . Nevertheless, most mothers are asymptomatic despite the presence of autoantibodies and are diagnosed with autoimmune diseases, such as systemic lupus erythematosus after diagnosis of congenital AV block or hydrops fetalis in the fetus or newborn 1) .
Additionally, fetal exposure to high titers of anti-SSA/Ro antibodies is strongly correlated with cardiac damage. Jaeggi et al.
reported that complete AV block occurred with anti-SSA/Ro levels >100 U/mL, but never occurred in cases with levels <50 U/mL 5) . In the present case, there was no clinical evidence of maternal autoimmune disease either before or during pregnancy, and close antenatal observation or management was not performed prior to delivery. The maternal titer of anti-SSA/ Ro was greater than 200 U/mL, and the infant had complete AV block.
A B [11] [12] [13] . However, early implantation in very young and small patients has a greater risk of poor cosmetic results with multiple scars, skin erosion and infection, lead extraction or fracture, generator migration, and re-implantation 14, 15) . Moreover, in preterm and low birth weight neonates, patients are very unstable in terms of undergoing such an invasive surgical procedure 9, 14) .
Temporary transcutaneous pacing could be one option for .
In Korea, a case of transient complete AV block was reported in a neonate with congenital myotonic dystrophy where temporary transcutaneous pacing was applied 4 hours after birth 16) . When compared with temporary epicardial pacing, the advantages of this technique are that it is non-invasive, relatively simple to use, and rapidly available after delivery 15) . Thermal injury caused by electrolytic reaction occasionally occurs at the site of electrode attachment, and children and infants are particularly susceptible. Moreover, physicians have had to tailor large adultsized external pacing electrodes for small preterm neonates, resulting in an increased risk of burns caused by the unprotected surfaces of the pacing electrodes. In order to prevent thermal injury, it is necessary to closely monitor electrode contact sites and use the lowest effective current 9, 15, 16) . As in our case, it may be helpful to wrap the margin of the tailored pacing electrodes with an insulating material to prevent thermal injury. In this case, we successfully stabilized a low birth weight, preterm neonate with congenital complete AV block with temporary transcutaneous pacing during a hemodynamically unstable period immediately after birth. We were further able to successfully discontinue pacing therapy after 3 days without bradycardia or hypotension.
Although there was thermal injury on the left chest, this healed completely and no major complications were experienced.
In conclusion, temporary transcutaneous pacing is a treatment option for a low birth weight, premature neonate with congenital
The clinical features of neonates with congenital complete AV block range from absence of any symptoms to severe heart failure and hydrops fetalis. Myocarditis, pericardial effusions, endocardial fibroelastosis, and dilated cardiomyopathy can all occur simultaneously with congenital AV block, with the most severe in utero complication being fetal death due to low cardiac output 6) . Indeed, the reported perinatal mortality rate is approximately 20-30% 2) . There is a particularly poor prognosis for cases with a heart rate below 50-55 BPM, fetal hydrops, endocardial fibroelastosis, impaired left ventricular function, or those at less than 20 gestational weeks 3, 6, 7) .
A This combination therapy may assist in the complete regression of first and second-degree AV block; however, it can only prevent cases of third-degree AV block from progressing to heart failure 4) .
Thus, perinatal management should be initiated as soon as possible.
If a fetus with third-degree, complete AV block shows fetal distress or deteriorating cardiac performance, delivery should be considered, which can be contributor to preterm birth. The management of premature infants with symptomatic complete AV block is challenging, and includes drug treatment, temporary cardiac pacing, and permanent pacemaker implantation 1) .
Drugs such as isoproterenol (β-adrenergic agonist), epinephrine, dopamine, and atropine are used to increase the infant's heart rate if it is below 60 BPM; however, these drugs are rarely successful. Immediate pacing should therefore be considered in most cases, even as a first strategy before commencing a drug trial 9) .
Indications for permanent pacemaker implantation with congenital complete AV block include patients with (1) symptomatic bradycardia, congestive heart failure, or low cardiac ourput; (2) a resting heart rate <55 BPM; (3) left ventricular dilatation or dysfunction; (4) pauses >3 seconds during Holter monitoring; (5) a broad ventricular escape rhythm (QRS duration >120
